Table 3.

Effects of interdisciplinary therapy in metabolic profile (factors associated with metabolic syndrome definition by International Diabetes Federation (IDF)).

Variables	Baseline	After therapy	P value	Δ value
Waist circumference (cm)	103.4 ± 10.7	94.4 ± 11.6	<0.001	−9.5 ± 18.32
Glucose (mg/dL)	90.5 ± 7.8	89.7 ± 7.7	0.43	0.77 ± 8.60
Insulin (µU/mL)	17.1 ± 8.0	12.0 ± 9.6	<0.001	−4.94 ± 10.50
HDL-cholesterol (mg/dL)	43.7 ± 8.6	45.3 ± 9.2	<0.001	1.80 ± 5.51
LDL-cholesterol (mg/dL)	102.4 ± 27.4	94.0 ± 24.0	<0.001	−9.98 ± 17.54
VLDL-cholesterol (mg/dL)	21.3 ± 9.4	17.8 ± 8.5	<0.001	−3.44 ± 8.06
Triglyceride (mg/dL)	111.2 ± 64.2	88.9 ± 42.6	<0.001	−21.27 ± 52.50
HOMA-IR	3.8 ± 2.0	2.7 ± 1.7	<0.001	−1.13 ± 3.00

HOMA-IR: homeostasis model assessment insulin-index resistance; HLD: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very-low-density lipoprotein. Reference values: glucose (60–110 mg/dL); insulin (<20 μU/mL); HOMA-IR (<2.0); total cholesterol (<170 mg/dL); Triglyceride (33–129 mg/dL); HDL cholesterol (>38 mg/dL); LDL cholesterol (<130 mg/dL); VLDL cholesterol (10–50 mg/dL) (2); statistical significance P ≤ 0.05.